April 24, 2014 4:07 AM ET

Biotechnology

Company Overview of Enanta Pharmaceuticals, Inc.

Key Executives for Enanta Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jay R. Luly Ph.D.39 RelationshipsChief Executive Officer, President and Director57
Paul J. Mellett Jr.No RelationshipsChief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance & Administration58
Timothy D. Ocain Ph.D.10 RelationshipsSenior Vice President of New Product Strategy and Development--
Yat Sun Or Ph.D.No RelationshipsChief Scientific Officer and Senior Vice President of Research & Development61

Enanta Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel Jan Ellens Ph.D. 41 RelationshipsLife Sciences Partners BV65
Jay R. Luly Ph.D. 39 RelationshipsEnanta Pharmaceuticals, Inc.57
Terry C. Vance 30 RelationshipsSaints Capital57
Stephen Buckley Jr. 15 RelationshipsEnanta Pharmaceuticals, Inc.64
Ernst-Günter Afting Ph.D., M.D. 70 RelationshipsSequenom Inc.71
View All Board Members

Enanta Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Stephen Buckley15 Relationships3 Executives
Nominating Committee Terry C. Vance30 Relationships5 Executives
Corporate Governance Committee Terry C. Vance30 Relationships5 Executives
Supervisory Board Ph.D.Daniel Jan Ellens41 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$448.5K
448.5K
364.2K
Bonus$235.4K
235.4K
219.0K
Total Short Term Compensation
Not meaningful
Total Value of Options$683.9K
683.9K
16.4M
Compensation as of Fiscal Year 2013
Enanta Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Lynda A. Kelly Joins as Senior Vice President, Care Business Area of Suominen Corporation, Effective May 12, 2014
April 22, 2014 12:00 AM ET
GP Batteries International Limited Announces Demise of its Chairman and Chief Executive, Andrew Ng Sung On
April 17, 2014 12:31 PM ET
Oil-Dri Corporation of America Appoints Mark E. Lewry as Chief Operating Officer
April 07, 2014 12:00 AM ET
National Detergent Appoints Anwar Ali Sultan as Temporary Director
April 02, 2014 12:00 AM ET
NVC Lighting Holding Limited Announces Executive Changes, Effective April 1, 2014
April 01, 2014 12:00 AM ET

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.